ストックスクリーナーアプリを入手
3.32
13.99%
-0.54
アフターアワーズ：
3.34
0.02
+0.60%
Lantern Pharma Inc (LTRN) 最新ニュース
Lantern Pharma Inc. (NASDAQ:LTRN) Q1 2025 Earnings Call Transcript - MSN
Lantern Pharma outlines commercialization of radar AI modules and expects LP-184 trial enrollment completion by June 2025 - MSN
Lake Street to Host Virtual Meeting Featuring LTRN on May 20 | L - GuruFocus
Lantern Pharma Advances AI-Driven Cancer Therapies - TipRanks
Lantern Pharma’s Earnings Call: Progress and Prospects - TipRanks
Lantern Pharma Q1 2025 slides: narrowing losses as clinical trials advance By Investing.com - Investing.com South Africa
Transcript : Lantern Pharma Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com
Lantern Pharma Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:LTRN) - Seeking Alpha
Earnings call transcript: Lantern Pharma Q1 2025 reports narrower loss - Investing.com
Lantern Pharma Q1 2025 slides: narrowing losses as clinical trials advance - Investing.com
Earnings call transcript: Lantern Pharma Q1 2025 reports narrower loss By Investing.com - Investing.com India
Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates | LTRN Stock News - GuruFocus
Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates - BioSpace
Lantern Pharma Reports Q1 2025 Financial Results - TipRanks
Lantern Pharma Inc. SEC 10-Q Report - TradingView
Yaber Highlights the Timeless Design and Natural Aesthetic of the T2 Series in "Lunar Rock" Colorway - Barchart.com
Why Beat Earnings When You Can Just Buy The Dip? - Barchart.com
BIG ROCK BREWERY INC. ANNOUNCES FIRST QUARTER 2025 RESULTS AND 51% INCREASE IN SALES VOLUMES - Barchart.com
The Ordre des arts et des lettres du Québec announces its 2025 cohortTen luminaries will become honorary members on June 9 - Barchart.com
Abigail Disney Urges Donors To Be Braver About Their Giving And Shouldering More Risk - Barchart.com
STATEMENTWith New Federal Health Minister Installed, It's Time To Get To Work: CMA - Barchart.com
Henry Mauriss Calls For A New Era Of Entrepreneurial Innovation In Media - Barchart.com
Phyllis Waud and Rebecca Murray of Syntax Named to CRN's 2025 Women of the Channel List - Barchart.com
Lantern Pharma Secures FDA Clearance for Planned Phase 1b/2 Tria - GuruFocus
Trump sets 30-day deadline for pharmaceutical companies to lower US drug prices in executive order - Barchart.com
Tino’s Tree Service VA Prioritizes Property Protection with Fully Insured, Expert-Guided Tree Solutions - Barchart.com
Hogs See Tuesday Strength - Barchart.com
FDA clears LP-184 trial for NSCLC patients with specific mutations - Investing.com Nigeria
FDA Clears Lantern Pharma's (LTRN) Clinical Trial Amendment for NSCLC Treatment | LTRN Stock News - GuruFocus
Lantern Pharma Secures FDA Clearance for Planned Phase 1b/2 Trial of LP-184 in Biomarker-Defined, Treatment-Resistant NSCLC Patients with High Unmet Clinical Need - NewsBreak: Local News & Alerts
FDA clears LP-184 trial for NSCLC patients with specific mutations By Investing.com - Investing.com South Africa
EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients - Benzinga
The Conference Of Montreal 2025: Change, Vector Of Opportunities - Barchart.com
Google will pay $1.4 billion to Texas to settle claims the company collected data on users without permission - Barchart.com
Lantern Pharma (LTRN) Gets FDA Clearance for Clinical Trial Targeting Treatment-Resistant, Genomically-Defined Lung Cancer with AI developed LP-184 - Barchart.com
Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET - BioSpace
Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET | LTRN Stock News - GuruFocus
Shootin' The Bull About Holding Ones Breath - Barchart.com
Ion Pure Review: Is IonPure The Best Air Purifier Of 2025? - Barchart.com
Renaissance Technologies LLC Grows Stock Position in Lantern Pharma Inc. (NASDAQ:LTRN) - Defense World
Soybeans Continue Slide On Tuesday - Barchart.com
Pastor Ryan Macdonald Shares His Journey of Faith and Leadership in Exclusive Online Interview - Barchart.com
Entrepreneur Brandon Erickson From Wisconsin Featured In Exclusive Interview Spotlight - Barchart.com
Thinkific Announces First Quarter 2025 Financial Results - Barchart.com
Maneskin Store Launches 2025 Summer Collection For Rock Fans Worldwide - Barchart.com
The End Of The Due Diligence Bottleneck? Valutico’s “Done Diligence” Arrives - Barchart.com
Ma Ai: Driving Singapore’s Digital Future Through Telecommunications Engineering - Barchart.com
Does Cotton Have A Chance To Rally In 2025? - Barchart.com
OSC Analysis Highlights Increasing Mentions And Diverging Sentiment In AI Disclosures - Barchart.com
Nova Scotia Fixed-Term Lease Loophole To Remain In Place Despite Some Abuse: Official - Barchart.com
Corn Slipping Into Midday Trade - Barchart.com
Mining Companies Recognized For Excellence In Responsible Mining - Barchart.com
No Bull | The Five Spot - Barchart.com
LTRN: IND Clearance for LP-184 in TNBC - MSN
East Side Games Group To Announce First Quarter 2025 Financial Results - Barchart.com
Cotton Pushing Back Lower On Tuesday Morning - Barchart.com
Bell Unveils Tech Services Brand Ateko, Merging Three Recently Acquired Companies - Barchart.com
Natural Gas Slowed Down For A Correction Within Uptrend - Barchart.com
Texas Roadhouse (TXRH) Q1 Earnings: What To Expect - Barchart.com
IBM Accelerates Enterprise Gen AI Revolution With Hybrid Capabilities - Barchart.com
2 Reasons To Like S And 1 To Stay Skeptical - Barchart.com
Lantern Advances Drug Candidate LP-184 with IND Clearance for Ph - GuruFocus
The Stonegate Firm Achieves Full BBB Accreditation And Maintains An A+ Rating - Barchart.com
Lantern Pharma (LTRN) Gains FDA Approval for Clinical Trial in B - GuruFocus
Corn Collapses Towards April Lows On Monday - Barchart.com
Car Haggle Helper Launches No-Risk Service That Saves New Car Buyers $4 – $8K on Average - Barchart.com
1.54%
7.58%
大文字化:
|
ボリューム (24 時間):